Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques

Stroke

Volumn 45, Issue 5, 2014, Pages 1248-1257

  Amarenco, Pierre ^a   Davis, Stephen ^d   Jones, Elizabeth F ^e   Cohen, Ariel A ^b   Heiss, Wolf Dieter ^f   Kaste, Markku ^g   Laouénan, Cédric ^c   Young, Dennis ^d,h   Macleod, Malcolm ^d,i   Donnan, Geoffrey A ^d   Bladin, Christopher F ^j   Chambers, Brian R ^j   Frayne, Judith ^j   Hankey, Graeme J ^j   Levi, Christopher R ^j   Read, Stephen J ^j   Ravaud, Philippe ^j   Tatlisumak, Turgut ^j   Soinne, Lauri ^j   Laine, Mika ^j   Syvänne, Mikko ^j   Vikatmaa, Pirkka ^j   Lepäntalo, Mauri ^j   Mentré, France ^j   Gosset, Simon ^j   Churilov, Leonid ^j   De Broucker, Thomas ^j   Favrole, Pascal ^j   Mawet, Jérôme ^j   Mocquard, Yves ^j   Obadia, Michael ^j   Godefroy, Olivier ^j   Hosseini, Hassan ^j   Pico, Fernando ^j   Garnier, Pierre ^j   Malbec, Marcel ^j   Pinel, Jean François ^j   Ille, Olivier ^j   Vadamme, Xavier ^j   Macian Montoro, Francisco ^j   Servan, Jérôme ^j   Viallet, François ^j   Rosolacci, Thierry ^j   Lecoz, Patrick ^j   Clavelou, Pierre ^j   Detante, Olivier ^j   Cho, Tae Hee ^j   Saudeau, Denis ^j   Michel, Patrik ^j   D'Ombrogio, Suzette ^j   Serisier, David ^j   Sturm, Jonathon ^j   Kimber, Thomas ^j   Marcus, Romesh ^j   Schwartz, Ray ^j   Helme, Rob ^j   Blacker, David ^j   Wood, Jonathan ^j   more..

^a BICHAT HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e AUSTIN HEALTH   (Australia)

^f MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j Division of Clinical Neurosciences University of Edinburgh ^*

more..

Author keywords

Aorta; Atherosclerosis; Cerebral infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA RUPTURE; AORTIC ARCH PLAQUE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIFFUSION WEIGHTED IMAGING; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SMOKING; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

AORTA; ATHEROSCLEROSIS; CEREBRAL INFARCTION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTA, THORACIC; AORTIC DISEASES; ASPIRIN; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; EMBOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STROKE; TICLOPIDINE; TREATMENT OUTCOME; WARFARIN;

EID: 84899756664     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.004251     Document Type: Article

References (40)

1. Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992;326:221-225.
2. Tunick PA, Perez JL, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991;115:423-427.
3. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331:1474-1479.
4. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995;26:218-224.
5. Di Tullio MR, Sacco RL, Gersony D, Nayak H, Weslow RG, Kargman DE, et al. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology. 1996;46:1560-1566.
6. Macleod M, Amarenco P, Davis SM, Donnan GA. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of ischemic stroke. Lancet Neurol. 2004;3:408-414.
7. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994;23:1085-1090.
8. Mitusch R, Doherty C, Wucherpfennig H, Memmesheimer C, Tepe C, Stierle U, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke. 1997;28:36-39.
9. Dávila-Román VG, Murphy SF, Nickerson NJ, Kouchoukos NT, Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol. 1999;33:1308-1316.
10. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser M-G, Amarenco P; FAPS Investigators. Aortic plaque morphology and vascular events. A follow-up study in patients with ischemic stroke. Circulation. 1997;96: 3838-3841.
11. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for reccurrent ischemic stroke. N Engl J Med. 1996;334:1216-1221.
12. Heinzlef O, Cohen A, Amarenco P. Update on aortic causes of ischemic stroke. Curr Opin Neurol. 1997;10:64-72.
13. Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, et al; NYU Atheroma Group. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320-1325.
14. Amarenco P, Röther J, Michel P, Davis SM, Donnan GA. Aortic arch atheroma and the risk of stroke. Curr Atheroscler Rep. 2006;8:343-346.
15. Hansson L, Hedner T, Dahlöf B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press. 1992;1:113-119.
16. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347:1713-1716.
17. Whitehead J. The Design and Analysis of Sequential Clinical Trials. 2nd ed. Chichester, United Kingdom: John Wiley & Sons; 1997.
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69: 236-239.
19. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
20. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, et al; PERFORM Study Investigators. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double- blind, parallel-group trial. Lancet. 2011;377:2013-2022.
21. Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP, et al. Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander? J Am Coll Cardiol. 2004;44:1018-1024.
22. SPARCLInvestigators, Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
23. PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
24. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in N Engl J Med. 2010;363:1877]. N Engl J Med. 2009;361:1139-1151.
25. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
26. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.
27. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31:1622-1626.
28. Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke. 2002;33:930-935.
29. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol. 1997;42:857-865.
30. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al; Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
31. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
32. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
33. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
34. Steinhubl SR, Berger PB, Mann JT, Fry ETA, DeLago A, Wilmer C, et al; CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA. 2002;288:2411-2420.
35. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.
36. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al; MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo- controlled trial. Lancet. 2004;364:331-337.
37. Azarpazhooh MR, Nicol MB, Donnan GA, Dewey HM, Sturm JW, Macdonell RA, et al. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke. 2008;3:158-164.
38. SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367:817-825.
39. Amarenco P, Donnan GA. Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke. 2004;35:2606-2608.
40. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11-19.